assumes, continues or substitutes the options and/or RSUs, as applicable, if the
named executive officer’s employment is terminated without cause or for good reason within 18 months following such change in control, the options and/or RSUs, as applicable, will become fully vested upon such termination. If the options and/or
RSUs, as applicable, are not assumed, continued or substituted in connection with a change in control, the options and/or RSUs, as applicable, will become fully vested as of such change in control.
Prior to Fiscal 2021, each of our named executive officers was issued two separate
grants of Class M Common Units of Mallard Holdco, LLC, a stockholder of the Company. In connection with our initial public offering, all vested and unvested Class M Common Units held by our named executive officers were redeemed by Mallard
Holdco, LLC in exchange for shares of our common stock under our 2021 Plan (either restricted or unrestricted, depending on the vested status of the Class M Common Units at the time of the IPO, with the restricted shares subject to the same
vesting schedule as the redeemed Class M Common Units). The Class M Common Units granted during Fiscal 2017 vested solely based on continued employment, with 20% of the underlying Class M Common Units vesting on each of the first five
anniversaries of the applicable vesting commencement date of the award and with the award vesting in full on the fourth anniversary of the applicable vesting commencement date as a result of the initial public offering having occurred prior to
such date. The Class M Common Units granted during Fiscal 2019 vested based on satisfaction of both employment- and performance-based vesting criteria. The employment-based vesting condition was satisfied upon continued employment, on the same
five-year schedule (with the award vesting in full on the fourth anniversary of the applicable vesting commencement date as a result of the initial public offering having occurred prior to such date) as the awards granted in Fiscal 2017, and the
performance-based vesting criteria were satisfied in connection with the initial public offering based on the offering price per share in the initial public offering.
The common stock or restricted common stock, as applicable, received by our named
executive officers in connection with our initial public offering has the same aggregate value as the vested Class M Common Units or unvested Class M Common Units, as applicable.
See the “Outstanding equity awards at fiscal year-end table” below for more
information regarding the outstanding equity awards held by our named executive officers as of July 31, 2021.
Agreements with our named executive officers
Each of our named executive officers is party to an amended and restated employment or
letter agreement with us that sets forth the terms and conditions of his or her employment. The material terms of these agreements are summarized below. As used in the summary below, the terms “cause” and “good reason” have the meanings set forth
in the applicable employment agreement.
Mr. Ryan. We entered into an
amended and restated employment agreement with Mr. Ryan in March 2021. Under the agreement, Mr. Ryan is entitled to receive a base salary and is eligible to receive an annual bonus with a target equal
to a percentage of his annual base salary, currently 100% of his annual base salary. If Mr. Ryan’s employment is terminated by us other than for cause or by
Mr. Ryan for good reason, he will be entitled to receive base salary continuation for twelve months, reimbursement of Consolidated Omnibus Budget Reconciliation Act premiums for up to twelve months
(based on the portion of monthly health premiums paid by us immediately prior to his termination), and any annual bonus for the fiscal year prior to the
fiscal year in which such termination occurs, to the extent not yet paid, in each case, subject to his execution of a separation agreement containing a general release of claims.
Ms. Beaudoin. We entered into an
amended and restated employment agreement with Ms. Beaudoin in March 2021. Under the agreement, Ms. Beaudoin is entitled to receive a base salary and is eligible to receive an annual bonus with a target equal to a percentage of her annual base salary, currently 60% of her annual base salary. If Ms. Beaudoin’s employment is terminated by us other than for cause or
by Ms. Beaudoin for good reason, she will be entitled to receive base salary continuation for twelve months, reimbursement of COBRA premiums for up to twelve months (based on the portion of monthly health premiums paid by us immediately prior to her termination), and any annual bonus for the fiscal year prior to the fiscal year in which such termination
occurs, to the extent not yet paid, in each case, subject to her execution of a separation agreement containing a general release of claims.
Mr. Przybylinski. We entered
into an amended and restated employment agreement with Mr. Przybylinski in March 2021. Under the agreement, Mr. Przybylinski is entitled to receive a base salary and is eligible to receive an annual bonus with a target equal to a percentage of his annual base salary, currently 50% of his annual base salary. If Mr. Przybylinski’s employment is terminated by us other
than for cause or by Mr. Przybylinski for good reason, he will be entitled to receive base salary continuation for twelve months, reimbursement of COBRA premiums for up